GTS-21 Reduces Inflammation in Acute Lung Injury by Regulating M1 Polarization and Function of Alveolar Macrophages

Shock. 2019 Mar;51(3):389-400. doi: 10.1097/SHK.0000000000001144.

Abstract

Background: Acute lung injury (ALI) is a severe outcome of sepsis. Alveolar macrophages (AMs) play key roles in defense, resolution in ALI. The polarization of AMs is dependent on micro environmental stimuli and might influence the progression of ALI. Gainesville Tokushima scientists (GTS)-21, a selective α7 nicotinic acetylcholine receptor agonist of the cholinergic anti-inflammatory pathway (CAP), has recently been established to be promising in the treatment of ALI. However, the molecular mechanism underlying the GTS-21-mediated suppression of inflammatory responses has been explored only partially. In this study, we examined the relation between GTS-21 and AM polarization in ALI.

Methods: The adoptive transfer of M1 (classically activated) and M2 (alternatively activated)-polarized AMs was performed to AM-depleted ALI mice, along with the administration of GTS-21 in a murine model of lipopolysaccharide (LPS)-induced ALI and in isolated AMs that had been stimulated by LPS in vitro.

Results: The adoptive transfer of M1-polarized AMs aggravated the inflammatory response in the lung in contrast to the adoptive transfer of M2-polarized AMs. GTS-21 protected the lung from the effect of LPS, preventing injury and decreasing the number of AMs, AM-related pro-inflammatory cytokine levels, high mobility group box 1 expression levels in AMs. In addition, GTS-21 significantly diminished the number of M1-polarized AM and increased the number of M2-polarized AM, by flow cytometry, RT-PCR, enzyme-linked immunosorbent assay, and the Arg1 and iNOS activity assays.

Conclusion: The GTS-21 substantially ameliorates LPS-induced ALI. This protection is predominantly associated with the inhibition of pulmonary AM M1 polarization and alteration in AM function.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Lung Injury / chemically induced
  • Acute Lung Injury / immunology
  • Acute Lung Injury / pathology
  • Acute Lung Injury / therapy*
  • Adoptive Transfer*
  • Animals
  • Benzylidene Compounds / pharmacology*
  • Inflammation
  • Lipopolysaccharides / toxicity
  • Macrophages, Alveolar / immunology*
  • Macrophages, Alveolar / pathology
  • Macrophages, Alveolar / transplantation
  • Mice
  • Nitric Oxide Synthase Type II / immunology
  • Pyridines / pharmacology*
  • Sepsis / chemically induced
  • Sepsis / immunology
  • Sepsis / pathology
  • Sepsis / therapy*

Substances

  • Benzylidene Compounds
  • Lipopolysaccharides
  • Pyridines
  • 3-(2,4-dimethoxybenzylidene)anabaseine
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse